Czechia· CZ-0273006
18F-FES
A fluoroestradiol 18f product containing fluoroestradiol (18f), registered in Czechia.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
The record
At a glance
SÚKL (Czech Republic)- Active substance
- FLUOROESTRADIOL (18F)
- Manufacturer
- —
- Country
- Czechia (CZ)
- ATC code
- V09IX11
- ATC class
- Fluoroestradiol 18F
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Fluoroestradiol 18f in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- France · Estrotep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c6443907-8b63-435d-90ba-854676ed8014 GET /v1/drugs/c6443907-8b63-435d-90ba-854676ed8014?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL",
"source": "sukl",
"strength": "1-8GBQ",
"pack_size": "7GBQ",
"substance": "FLUOROESTRADIOL (18F)",
"cz_kod_sukl": "0273006",
"product_type": "RA",
"substance_codes": "19893",
"registration_state": "F",
"registration_number": null
}See everything about fluoroestradiol 18f.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.